• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

追踪 15 个西非国家 COVID-19 疫苗接种覆盖率的上升和轨迹:一项中期分析。

Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis.

机构信息

Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK

Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

出版信息

BMJ Glob Health. 2021 Dec;6(12). doi: 10.1136/bmjgh-2021-007518.

DOI:10.1136/bmjgh-2021-007518
PMID:34906987
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8718349/
Abstract

The African Union Bureau of Heads of State and Government endorsed the COVID-19 Vaccine Development and Access Strategy to vaccinate at least 60% of each country's population with a safe and efficacious vaccine by 2022, to achieve the population-level immunity needed to bring the pandemic under control. Using publicly available, country-level population estimates and COVID-19 vaccination data, we provide unique insights into the uptake trends of COVID-19 vaccinations in the 15 countries that comprise the Economic Community of West Africa States (ECOWAS). Based on the vaccination rates in the ECOWAS region after three months of commencing COVID-19 vaccinations, we provide a projection of the trajectory and speed of vaccination needed to achieve a COVID-19 vaccination coverage rate of at least 60% of the total ECOWAS population. After three months of the deployment of COVID-19 vaccines across the ECOWAS countries, only 0.27% of the region's total population had been fully vaccinated. If ECOWAS countries follow this trajectory, the sub-region will have less than 1.6% of the total population fully vaccinated after 18 months of vaccine deployment. Our projection shows that to achieve a COVID-19 vaccination coverage of at least 60% of the total population in the ECOWAS sub-region after 9, 12 and 18 months of vaccine deployment; the speed of vaccination must be increased to 10, 7 and 4 times the current trajectory, respectively. West African governments must deploy contextually relevant and culturally acceptable strategies for COVID-19 vaccine procurements, distributions and implementations in order to achieve reasonable coverage and save lives, sooner rather than later.

摘要

非洲联盟国家元首和政府首脑局核可了《COVID-19 疫苗开发和获取战略》,目标是到 2022 年为每个国家至少 60%的人口接种安全有效的疫苗,以实现控制大流行所需的人群免疫力。利用公开的国家人口估计数和 COVID-19 疫苗接种数据,我们深入了解了西部非洲国家经济共同体(西非经共体)15 个成员国 COVID-19 疫苗接种的采用趋势。根据 COVID-19 疫苗接种开始三个月后西非经共体区域的接种率,我们对实现 COVID-19 疫苗接种覆盖率至少达到西非经共体总人口 60%所需的接种轨迹和速度进行了预测。在 COVID-19 疫苗在西非经共体国家部署三个月后,该区域只有 0.27%的总人口完全接种了疫苗。如果西非经共体国家遵循这一轨迹,那么在疫苗部署 18 个月后,该次区域将只有不到 1.6%的人口完全接种疫苗。我们的预测表明,要在 COVID-19 疫苗部署 9、12 和 18 个月后,使西非经共体次区域至少 60%的总人口得到疫苗接种,接种速度必须分别提高到目前轨迹的 10、7 和 4 倍。西非各国政府必须部署符合具体国情和文化可接受的 COVID-19 疫苗采购、分配和实施战略,以便尽早实现合理的覆盖范围并拯救生命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/73a78d5b6e42/bmjgh-2021-007518f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/08d3d52060d1/bmjgh-2021-007518f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/df9b096f978a/bmjgh-2021-007518f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/51cfed44fcd7/bmjgh-2021-007518f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/73a78d5b6e42/bmjgh-2021-007518f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/08d3d52060d1/bmjgh-2021-007518f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/df9b096f978a/bmjgh-2021-007518f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/51cfed44fcd7/bmjgh-2021-007518f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d5/8718349/73a78d5b6e42/bmjgh-2021-007518f04.jpg

相似文献

1
Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis.追踪 15 个西非国家 COVID-19 疫苗接种覆盖率的上升和轨迹:一项中期分析。
BMJ Glob Health. 2021 Dec;6(12). doi: 10.1136/bmjgh-2021-007518.
2
COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness.52 个非洲国家的 COVID-19 疫苗接种实施情况:轨迹和对未来大流行防范的影响。
BMJ Glob Health. 2023 Dec 6;8(12):e013073. doi: 10.1136/bmjgh-2023-013073.
3
Association between Gross National Income per capita and COVID-19 vaccination coverage: a global ecological study.人均国民总收入与 COVID-19 疫苗接种覆盖率之间的关系:一项全球生态学研究。
BMC Public Health. 2023 Dec 4;23(1):2415. doi: 10.1186/s12889-023-17241-y.
4
Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.非洲 COVID-19 疫苗接种率低:当前证据和前进道路。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2034457. doi: 10.1080/21645515.2022.2034457. Epub 2022 Mar 3.
5
COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.COVID-19 发病率与区域检测策略、疫苗接种覆盖率和疫苗类型的关系。
Viruses. 2023 Oct 30;15(11):2181. doi: 10.3390/v15112181.
6
The first year of the COVID-19 pandemic in the ECOWAS region.西非国家经济共同体地区的 COVID-19 大流行第一年。
Ghana Med J. 2022 Sep;56(3 Suppl):61-73. doi: 10.4314/gmj.v56i3s.8.
7
COVID-19 pandemic in Economic Community of West African States (ECOWAS) region: implication for capacity strengthening at Point of Entry.西非国家经济共同体(西非经共体)区域的 COVID-19 大流行:对入境点能力建设的影响。
Pan Afr Med J. 2021 May 25;39:67. doi: 10.11604/pamj.2021.39.67.29089. eCollection 2021.
8
Variations in COVID-19 vaccine hesitancy over time: a serial cross-sectional study in five West African countries.新冠疫苗犹豫度随时间变化情况:五个西非国家的连续横断面研究。
BMJ Open. 2024 Nov 7;14(11):e083766. doi: 10.1136/bmjopen-2023-083766.
9
Vaccination coverage and access among children and adult migrants and refugees in the Middle East and North African region: a systematic review and meta-analysis.中东和北非地区儿童及成年移民与难民的疫苗接种覆盖率及可及性:一项系统评价与荟萃分析
EClinicalMedicine. 2024 Nov 22;78:102950. doi: 10.1016/j.eclinm.2024.102950. eCollection 2024 Dec.
10
Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India.新冠疫情期间妊娠期疫苗接种接受度的影响因素:来自印度西孟加拉邦的一项多中心研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2383030. doi: 10.1080/21645515.2024.2383030. Epub 2024 Jul 31.

引用本文的文献

1
A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries.一种用于建模影响非洲国家 COVID-19 疫苗接种部署的因素的方案。
PLoS One. 2024 Nov 7;19(11):e0311800. doi: 10.1371/journal.pone.0311800. eCollection 2024.
2
"I'd just love to hear what the community has to say": Exploring the potential of community-driven vaccine messaging amongst ethnic minority communities.“我非常想听一听社区的意见”:探索在少数族裔社区中开展社区驱动型疫苗宣传的潜力。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2423469. doi: 10.1080/21645515.2024.2423469. Epub 2024 Nov 5.
3
Exploring the perceptions and experiences of mobile teams on COVID-19 vaccine uptake at the community level: evidence from Benue and Niger states.

本文引用的文献

1
Priorities for global access to life-saving interventions during public health emergencies: Crisis nationalism, solidarity or charity?全球公共卫生紧急情况下获取救命干预措施的优先事项:危机民族主义、团结还是慈善?
Glob Public Health. 2022 Aug-Sep;17(9):1785-1794. doi: 10.1080/17441692.2021.1977973. Epub 2021 Sep 23.
2
Examining Vaccine Hesitancy in Sub-Saharan Africa: A Survey of the Knowledge and Attitudes among Adults to Receive COVID-19 Vaccines in Ghana.审视撒哈拉以南非洲地区的疫苗犹豫现象:加纳成年人对新冠疫苗接种的知识与态度调查
Vaccines (Basel). 2021 Jul 22;9(8):814. doi: 10.3390/vaccines9080814.
3
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.
探索社区层面移动团队对 COVID-19 疫苗接种的看法和经验:来自贝努埃州和尼日尔州的证据。
BMC Public Health. 2024 Jul 25;24(1):1996. doi: 10.1186/s12889-024-19562-y.
4
Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study.尼日利亚SARS-CoV-2快速诊断检测的性能评估:一项横断面研究。
PLOS Glob Public Health. 2024 Jul 15;4(7):e0003371. doi: 10.1371/journal.pgph.0003371. eCollection 2024.
5
Health Planning in Times of COVID-19 in Burkina Faso: The Role of Its National Strategic Pandemic Management Committee.布基纳法索新冠疫情期间的卫生规划:国家战略大流行管理委员会的作用
Community Health Equity Res Policy. 2025 Jul;45(4):375-384. doi: 10.1177/2752535X241256414. Epub 2024 May 30.
6
Vaccine inequity: a threat to Africa's recovery from COVID-19.疫苗不平等:对非洲从新冠疫情中复苏的威胁。
Trop Med Health. 2023 Dec 19;51(1):69. doi: 10.1186/s41182-023-00564-2.
7
COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness.52 个非洲国家的 COVID-19 疫苗接种实施情况:轨迹和对未来大流行防范的影响。
BMJ Glob Health. 2023 Dec 6;8(12):e013073. doi: 10.1136/bmjgh-2023-013073.
8
Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria.减少尼日利亚民众对新冠疫苗的犹豫态度并提高疫苗接种率。
J Public Health Afr. 2023 May 4;14(5):2290. doi: 10.4081/jphia.2023.2290. eCollection 2023 Apr 30.
9
Determinants of COVID-19 vaccine uptake among Nigerians: evidence from a cross-sectional national survey.尼日利亚人接种新冠疫苗的决定因素:来自全国横断面调查的证据。
Arch Public Health. 2023 May 26;81(1):95. doi: 10.1186/s13690-023-01107-1.
10
Public relations strategies employed by the Ghana Health Service to address COVID-19 vaccine hesitancy: a qualitative inquiry.加纳卫生服务局为应对新冠疫苗犹豫情绪所采用的公共关系策略:一项定性调查
Trop Med Health. 2023 May 12;51(1):26. doi: 10.1186/s41182-023-00519-7.
新冠病毒疫苗在中低收入国家的接受程度和犹豫。
Nat Med. 2021 Aug;27(8):1385-1394. doi: 10.1038/s41591-021-01454-y. Epub 2021 Jul 16.
4
Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.超越疫苗犹豫:在新冠疫苗民族主义不断抬头的背景下,非洲是时候扩大疫苗生产能力了。
Lancet Microbe. 2021 Aug;2(8):e347-e348. doi: 10.1016/S2666-5247(21)00126-9. Epub 2021 Jun 18.
5
Acceptability of COVID-19 Vaccine in Africa.新冠疫苗在非洲的可接受性。
Int J MCH AIDS. 2021;10(1):134-138. doi: 10.21106/ijma.482. Epub 2021 Apr 8.
6
Addressing challenges to rolling out COVID-19 vaccines in African countries.应对非洲国家推广新冠疫苗的挑战。
Lancet Glob Health. 2021 Jun;9(6):e746-e748. doi: 10.1016/S2214-109X(21)00097-8. Epub 2021 Mar 10.
7
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.确保全球公平获得 COVID-19 疫苗面临的挑战:生产、可负担性、分配和部署。
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
8
Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.应对非洲的疫苗犹豫:预期的 COVID-19 疫苗背景。
Pan Afr Med J. 2021 Jan 5;38:3. doi: 10.11604/pamj.2021.38.3.27401. eCollection 2021.
9
A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries.一种基于系统记分卡的方法,用于在受影响国家为拉沙热疫苗临床试验做准备时进行现场评估。
Pilot Feasibility Stud. 2020 Feb 13;6:24. doi: 10.1186/s40814-020-00567-4. eCollection 2020.